RVL Pharmaceuticals (RVLP) Q3 2022 Earnings

10NovConfirmed
Nov 21
May 22
Aug 22
Q3 2022
-0.31
-0.23
-0.16
-0.08

Details

Expected EPS
-0.16
Actual EPS
-0.16
Surprise EPS
0
Surprise Percent
+0%

Description

RVL Pharmaceuticals (RVLP) has reported earnings of -0.16 per share for Q3 2022.

0 Comments

Share your thoughts